SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Tyler N. Starr(Fred Hutch Cancer Center), Nadine Czudnochowski(VIR Biotechnology (United States)), Zhuoming Liu(Washington University in St. Louis), Fabrizia Zatta(Vir Biotechnology (Switzerland)), Young‐Jun Park(University of Washington), Amin Addetia(Fred Hutch Cancer Center), Dora Pinto(Vir Biotechnology (Switzerland)), Martina Beltramello(Vir Biotechnology (Switzerland)), Patrick Hernandez(VIR Biotechnology (United States)), Allison J. Greaney(University of Washington), Roberta Marzi(Vir Biotechnology (Switzerland)), William G. Glass(Memorial Sloan Kettering Cancer Center), Ivy Zhang(Memorial Sloan Kettering Cancer Center), Adam S. Dingens(Fred Hutch Cancer Center), John E. Bowen(University of Washington), M. Alejandra Tortorici(University of Washington), Alexandra C. Walls(University of Washington), Jason A. Wojcechowskyj(VIR Biotechnology (United States)), Anna De Marco(Vir Biotechnology (Switzerland)), Laura E. Rosen(VIR Biotechnology (United States)), Jiayi Zhou(VIR Biotechnology (United States)), Martin Montiel-Ruiz(VIR Biotechnology (United States)), Hannah Kaiser(VIR Biotechnology (United States)), Josh R. Dillen(VIR Biotechnology (United States)), Heather Tucker(VIR Biotechnology (United States)), Jessica Bassi(Vir Biotechnology (Switzerland)), Chiara Silacci-Fregni(Vir Biotechnology (Switzerland)), Michael P. Housley(VIR Biotechnology (United States)), Julia di Iulio(VIR Biotechnology (United States)), Gloria Lombardo(Vir Biotechnology (Switzerland)), Maria L. Agostini(VIR Biotechnology (United States)), Nicole Sprugasci(Vir Biotechnology (Switzerland)), Katja Culap(Vir Biotechnology (Switzerland)), Stefano Jaconi(Vir Biotechnology (Switzerland)), Marcel Meury(VIR Biotechnology (United States)), Exequiel Dellota(VIR Biotechnology (United States)), Rana Abdelnabi(Rega Institute for Medical Research), Caroline S. Foo(Rega Institute for Medical Research), Elisabetta Cameroni(Vir Biotechnology (Switzerland)), Spencer Stumpf(Washington University in St. Louis), Tristan I. Croll(University of Cambridge), Jay C. Nix(Lawrence Berkeley National Laboratory), Colin Havenar‐Daughton(VIR Biotechnology (United States)), Luca Piccoli(Vir Biotechnology (Switzerland)), Fabio Benigni(Vir Biotechnology (Switzerland)), Johan Neyts(Rega Institute for Medical Research), Amalio Telenti(VIR Biotechnology (United States)), Florian A. Lempp(VIR Biotechnology (United States)), Matteo Samuele Pizzuto(Vir Biotechnology (Switzerland)), John D. Chodera(Memorial Sloan Kettering Cancer Center), Christy M. Hebner(VIR Biotechnology (United States)), Herbert W. Virgin(Washington University in St. Louis), Sean P. J. Whelan(Washington University in St. Louis), David Veesler(University of Washington), Davide Corti(Vir Biotechnology (Switzerland)), Jesse D. Bloom(University of Washington), Gyorgy Snell(VIR Biotechnology (United States))
Cited by 583Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis